Skip to main content
. Author manuscript; available in PMC: 2017 Mar 15.
Published in final edited form as: J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Feb 9;1015-1016:34–41. doi: 10.1016/j.jchromb.2016.02.012

Figure 4.

Figure 4

Fecal profile of irinotecan, SN-38 and SN-38 glucuronide in feces collected for 24 hours, after intravenous administration of 5 mg/kg irinotecan